This browser is not actively supported anymore. For the best passle experience, we strongly recommend you upgrade your browser.

United Kingdom | EN-GB

Cortex - Life Sciences Insights

Joost Haans

Partner, Competition , DLA Piper

Brussels

Nov 06, 2023

The EU Foreign Subsidies Regulation - life sciences companies impacted by EC review of transactions and public procurement

By Joost Haans Anna Sacco

On 12 October 2023, EU Foreign Subsidies Regulation (“FSR”) filings to the European Commission (“EC”) became mandatory. In addition to...

May 29, 2023

EU Pharma Law Forum 2023 - competition highlights

By Joost Haans

On 23 May 2023, Joost Haans from our Life Sciences team attended the EU Pharma Law Forum in Brussels where he participated in the...

Oct 21, 2022

Advocate General against a stricter standard of proof of harm in merger cases

By Joost Haans

Yesterday (20 October 2022), Advocate General (AG) Kokott of the European Court of Justice issued her Opinion in relation to the appeal...

DLA Piper is a global law firm operating through various separate and distinct legal entities. For further information about these entities and DLA Piper's structure, please refer to the Legal Notices page of this website. All rights reserved. Attorney advertising.